News release: New Pending Patent with Continuation-In-Part May 2024

  • Home
  • Next Generation Treatment
  • Potential Uses
  • Dr. Brown's Blog
  • About US
  • Contact and License
  • Understand the Market
  • Patient Case Studies
  • Inspect Patents Pending
  • Resources
  • Alzheimer's Research
  • NeoHack News
  • More
    • Home
    • Next Generation Treatment
    • Potential Uses
    • Dr. Brown's Blog
    • About US
    • Contact and License
    • Understand the Market
    • Patient Case Studies
    • Inspect Patents Pending
    • Resources
    • Alzheimer's Research
    • NeoHack News
  • Home
  • Next Generation Treatment
  • Potential Uses
  • Dr. Brown's Blog
  • About US
  • Contact and License
  • Understand the Market
  • Patient Case Studies
  • Inspect Patents Pending
  • Resources
  • Alzheimer's Research
  • NeoHack News

Restoring Homeostasis: The Next Generation

Restoring Homeostasis: The Next Generation Restoring Homeostasis: The Next Generation Restoring Homeostasis: The Next Generation Restoring Homeostasis: The Next Generation

NeoHack Life Sciences Principals

Chief Executive Officer

Ron Butler, MBA

Scottsdale, AZ

Previously Chairman and CEO, EVP, and CMO of NYSE, AMEX and NASDQ traded companies

in pet products industry, home centers, hardware distribution, and furniture manufacturing 

Former EVP PetSMART

Board Committees: Corporate Governace, Audit, Compensation

20 year member Wake Forest Business School Board

Pro Humanitate Society

Pepperdine University  Board, former member

contact: rb@neohacksciences.com

Chief Science Officer

Dr. Dale Brown, PhD

Wharton, TX

Authored and Co-Authored over 40 PATENTS

Homeostasis Researcher 

Inflammation Researcher using components of the Inflammasomes

Recipient, American Cyanamid's Scientific Achievement Award

Published Academic Author

Chemical Synthesis and Formulation expert

University of North Texas (Formerly North Texas State University)

contact: db@neohacksciences.com


The NeoHack Story

  

The accidental discovery of penicillin by Sir Alexander Fleming is legend, but most discoveries are not accidental and often result from corroborating observations and following scientific methods.


Such is the case with NeoHack Life Sciences, LLC. Our origins are based in an FDA licensed environment commanding rigid Good Manufacturing Practices to make ingredients and formulations for some of the most recognizable brands in the worldwide oral care markets.


Many of those formulations are availble through drug stores, mass merchant retailers and internet merchant sites today.


Out of our 30-year body of oral health work, a pleasant formulation emerged -- a dry mouth remedy owned by NeoHack -- branded as Hydralief. Its science was sound, and it was no accident that the healing effects for xerostomia (dry mouth) led to other discoveries. It was found to be effective for healing in mucosal tissues—and then in stopping herpes simplex (cold sores) -- and for other dermal issues via topical application.


As good scientists do, we “followed the science” from our dry mouth invention and discovered that a key ingredient derived from an African flower was dubbed “the toothache plant”. Hence the journey from dry mouth to pain relief began. 


NeoHack is excited about The NEXT GENERATION of malady treatments and believes that its focus on restoring the body’s homeostasis will change the field of pain relief for years to come. 


Keep following our website, www.NeoHackSciences.com, for developing research on Alzheimer’s, inflammation, inflammasomes, migraines, and other non-homeostasis-related ailments.

Back to Top

Copyright © 2023 NeoHackLife Sciences, LLC - All Rights Reserved


info@neohacksciences.com

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close